v3.20.1

Segment information (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2019
Segment information |
Segment information | Segment information for year 2019 (Euro, in thousands)
|  | R&D |  | Fee-for-services |  | Inter-segment elimination |  | Group
External revenue |  | € | 834,901 |  | € | 10,084 |  |  |  |  | € | 844,985
Internal revenue |  |  |  |  |  | 6,742 |  | € | (6,742) |  |  |
Other income |  |  | 50,905 |  |  | — |  |  |  |  |  | 50,905
Revenues & other income |  |  | 885,806 |  |  | 16,826 |  |  | (6,742) |  |  | 895,890
Segment result |  |  | 407,464 |  |  | 1,125 |  |  |  |  |  | 408,589
Unallocated expenses (1) |  |  |  |  |  |  |  |  |  |  |  | (38,297)
Operating income |  |  |  |  |  |  |  |  |  |  |  | 370,292
Financial (expenses)/income |  |  |  |  |  |  |  |  |  |  |  | (220,233)
Result before tax |  |  |  |  |  |  |  |  |  |  |  | 150,060
Income taxes |  |  |  |  |  |  |  |  |  |  |  | (214)
Net income |  |  |  |  |  |  |  |  |  |  | € | 149,845
| (1) |  | The unallocated expenses of €38,297 thousand comprise warrant costs.
Segment information for year 2018 (Euro, in thousands)
|  | R&D |  | Fee-for-services |  | Inter-segment elimination |  | Group
External revenue |  | € | 278,666 |  | € | 10,170 |  |  |  |  | € | 288,836
Internal revenue |  |  |  |  |  | 8,508 |  | € | (8,508) |  |  |
Other income |  |  | 29,000 |  |  | 9 |  |  |  |  |  | 29,009
Revenues & other income |  |  | 307,666 |  |  | 18,687 |  |  | (8,508) |  |  | 317,845
Segment result |  |  | (19,734) |  |  | 1,751 |  |  |  |  |  | (17,983)
Unallocated expenses (1) |  |  |  |  |  |  |  |  |  |  |  | (26,824)
Operating loss |  |  |  |  |  |  |  |  |  |  |  | (44,807)
Financial (expenses)/income |  |  |  |  |  |  |  |  |  |  |  | 15,598
Result before tax |  |  |  |  |  |  |  |  |  |  |  | (29,209)
Income taxes |  |  |  |  |  |  |  |  |  |  |  | (50)
Net loss |  |  |  |  |  |  |  |  |  |  | € | (29,259)
| (1) |  | The unallocated expenses of €26,824 thousand principally comprise of €26,757 thousand of warrant costs.
Segment information for year 2017 (Euro, in thousands)
|  | R&D |  | Fee-for-services |  | Inter-segment elimination |  | Group
External revenue |  | € | 118,262 |  | € | 8,825 |  |  |  |  | € | 127,087
Internal revenue |  |  |  |  |  | 5,104 |  | € | (5,104) |  |  |
Other income |  |  | 28,815 |  |  | 15 |  |  |  |  |  | 28,830
Revenues & other income |  |  | 147,077 |  |  | 13,945 |  |  | (5,104) |  |  | 155,918
Segment result |  |  | (73,610) |  |  | 86 |  |  |  |  |  | (73,524)
Unallocated expenses (1) |  |  |  |  |  |  |  |  |  |  |  | (16,278)
Operating loss |  |  |  |  |  |  |  |  |  |  |  | (89,802)
Financial (expenses)/income |  |  |  |  |  |  |  |  |  |  |  | (25,705)
Result before tax |  |  |  |  |  |  |  |  |  |  |  | (115,507)
Income taxes |  |  |  |  |  |  |  |  |  |  |  | (198)
Net loss |  |  |  |  |  |  |  |  |  |  | € | (115,704)
| (1) |  | The unallocated expenses of €16,278 thousand principally comprise of €16,536 thousand of warrant costs.
Summary of revenues by destination |
|  | Year ended December 31,
|  | 2019 |  | 2018 |  | 2017
|  | (Euro, in thousands)
North America |  | € | 795,605 |  | € | 117,609 |  | € | 82,050
Europe |  |  | 49,018 |  |  | 171,113 |  |  | 45,037
Asia Pacific |  |  | 362 |  |  | 114 |  |  | —
Total |  | € | 844,985 |  | € | 288,836 |  | € | 127,087
Summary of revenues by major customers |
|  | Year ended December 31,
|  | 2019 |  | 2018 |  |  | 2017
Spilt up of revenues by major customers |  | (Euro, in thousands) |  | % |  | (Euro, in thousands) |  | % |  | (Euro, in thousands) |  | %
Gilead: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
North America (1) |  | € | 793,873 |  | 94% |  | € | 116,640 |  | 40% |  | € | 80,687 |  | 63%
Europe (1) |  |  | (4,570) |  | -1% |  |  | 7,793 |  | 3% |  |  |  |  |
AbbVie: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Europe |  |  | 26,356 |  | 3% |  |  | 89,936 |  | 31% |  |  | 34,049 |  | 27%
Novartis: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Europe |  |  | 19,177 |  | 2% |  |  | 55,218 |  | 19% |  |  |  |  |
Les Laboratoires Servier: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Europe |  |  | — |  | 0% |  |  | 9,000 |  | 3% |  |  | 67 |  | 0%
Total revenues from major customers |  | € | 834,836 |  | 99% | € |  | 278,587 |  | 96% |  |  | 114,804 |  | 90%
Following the contract amendment, the revenue recognized for filgotinib for the year ended December 31, 2019, included a negative catch-up effect on closing date of €245.9 million resulting from the decrease in the percentage of completion applied to previously received upfront and milestones for that program.

X
- Definition The disclosure of geographical information. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2019-01-01 -Paragraph 33 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2019-en-r&anchor=para_33&doctype=Standard -URIDate 2019-03-27 + Details
Name: | ifrs-full_DisclosureOfGeographicalAreasExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ifrs-full_DisclosureOfOperatingSegmentsAbstract
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of operating segments. [Refer: Operating segments [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2019-01-01 -Paragraph 23 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2019-en-r&anchor=para_23&doctype=Standard -URIDate 2019-03-27 + Details
Name: | ifrs-full_DisclosureOfOperatingSegmentsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of major customers. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2019-01-01 -Paragraph 34 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2019-en-r&anchor=para_34&doctype=Standard -URIDate 2019-03-27 + Details
Name: | ifrs-full_DisclosureOfSegmentsMajorCustomersExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration